Falls are the leading cause of injury among older adults

PGx for Older Adults

Providers caring for older adults may benefit from using PGx to support personalizing complex and delicate treatment plans.

The AccessDx PGx Profile:

  • Supports polypharmacy management
  • Can help reduce adverse drug events, including falls
  • Helps shorten trial-and-error prescribing
  • Helps avoid prescribing cascades

Fill out this form to learn more details about PGx for older adults.

Name
By filling out this form, you agree to receive communications like newsletters, marketing or promotional materials, and other information from AccessDx Laboratory and our parent company, Aranscia®. You may opt-out of receiving communications from us by using the unsubscribe link at the bottom of all emails or contacting us directly.

65% of residents in long-term care facilities take ten or more medications2

90% of older adults reported using prescription medications in the last 12 months

Testing Options:

PGx Profile – Comprehensive Panel

Includes 37+ high-evidence and emerging-evidence genes, with four add-on genes available (APOE and HLA risk alleles)

PGx Profile – Focused Panel

Includes 20 high-evidence genes with actionable guidance, including HLA risk alleles

Therapeutic Areas Impacted:

Anestheisology
Behavioral Health
Cardiology
Dermatology

Endocrinology
Gastroenterology
Genitourinary
Hematology

Infectious Disease
Neurology
Oncology & Immunology
Opthalmology

Otolaryngology
Pain Medicine
Rheumatology
Transplant

  1. Administration for Community Living. 2023 Profile of Older Americans. U.S. Department of Health and Human Services, 2023, https://acl.gov/sites/default/files/Profile%20of%20OA/ACL_ProfileOlderAmericans2023_508.pdf
  2. Jokanovic, Natali et al. “Prevalence and Variability in Medications Contributing to Polypharmacy in Long-Term Care Facilities.” Drugs – real world outcomes vol. 4,4 (2017): 235-245. doi:10.1007/s40801-017-0121-x
  3. Ming, Yu, and Aleksandra Zecevic. “Medications & Polypharmacy Influence on Recurrent Fallers in Community: a Systematic Review.” Canadian geriatrics journal : CGJ vol. 21,1 14-25. 26 Mar. 2018, doi:10.5770/cgj.21.268
  4. Brixner D, Biltaji E, Bress A, et al. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. J Med Econ. 2016;19(3):213-228.doi:10.3111/13696998. 2015.1110160